Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +3.3% | -0.3% | 2 / 3 | +3.4% | -1.30 pp | -0.00 pp | +17.7% | 0.01 | 11.87 | 142 | +3,4% | 12,5 | +3,3% | 11.87 | 12.19 | −2,6% |
| Pts | 0 | 0 | 8 | 0 | 4 | 4 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 58.500 (close price on 2026-10-09)EPS (TTM): 4.928
Financial charts
1.Revenue & growth
VND bn142Q3/26
1.Revenue & growth
VND bn142Q3/26
2.Profit & growth
VND bn12,5Q3/26
3.Profit mix (Penman)
VND bn57,5Q3/26
4.Margins & cost structure
%37.3%Q3/26
5.Returns & cash cycle
% · days27.1%Q3/26
6.Earnings quality & cash
VND bn37,4Q3/26
7.Asset structure
VND bn370Q3/26
8.Funding & debt health
VND bn · times370Q3/26
9.Revenue backlog
VND bn2,62Q3/26
10.Valuation
times · %11,9×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.331Q3/26
Adjusted EPS growth, latest quarter
3.3%
Average adjusted EPS growth, 3 quarters
-1.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26